Science Explorer Back to mapMap

Most cited papers in Cancer Research and Treatments

What are the most cited papers in Cancer Research and Treatments?

The most cited paper in Cancer Research and Treatments is "Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma" (Roger Stupp, Warren P. Mason, Martin J. van den Bent et al., 2005), with 22,109 citations. Next come "Hallmarks of Cancer: New Dimensions" (9,794) and "Microenvironmental regulation of tumor progression and metastasis" (8,290).

Showing 50 of 100 papers. Every paper with more than 1,547 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren P. Mason, Martin J. van den Bent et al. · New England Journal of Medicine Open access 9 Mar 2005 22,109
2 Hallmarks of Cancer: New Dimensions Douglas Hanahan · Cancer Discovery Open access 2022 9,794
3 Microenvironmental regulation of tumor progression and metastasis Daniela F. Quail, Johanna A. Joyce · Nature Medicine Open access Nov 2013 8,290
4 Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Roger Stupp et al. · The Lancet Oncology 10 Mar 2009 7,889
5 Specific Association of Human Telomerase Activity with Immortal Cells and Cancer Nam W. Kim, Mieczyslaw A. Piatyszek, Karen R. Prowse et al. · Science 23 Dec 1994 7,190
6 Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer Edward B. Garon et al. · New England Journal of Medicine Open access 19 Apr 2015 6,312
7 Protein production by auto-induction in high-density shaking cultures F. William Studier · Protein Expression and Purification 8 Feb 2005 6,238
8 Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy Rakesh K. Jain · Science 6 Jan 2005 5,534
9 Cancer Cell Cycles Charles J. Sherr · Science 6 Dec 1996 5,411
10 A Perspective on Cancer Cell Metastasis Christine Louise Chaffer, Robert A. Weinberg · Science 24 Mar 2011 4,934
11 The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Isaiah J. Fidler · Nature reviews. Cancer Review 30 May 2003 4,744
12 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Lawrence A. Donehower, Michele Harvey, Betty L. Slagle et al. · Nature Mar 1992 4,702
13 Mdm2 promotes the rapid degradation of p53 Ygal Haupt, Ruth Ben-Yakar Maya, Anat Kazaz et al. · Nature May 1997 4,575
14 The biology and function of fibroblasts in cancer Raghu K. Kalluri · Nature reviews. Cancer Review 23 Aug 2016 4,462
15 Tumor Metastasis: Molecular Insights and Evolving Paradigms Scott Valastyan, Robert A. Weinberg · Cell Open access Oct 2011 4,179
16 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Catherine Adell O'Brien, Aaron F. Pollett, Steven Gallinger et al. · Nature 19 Nov 2006 4,107
17 Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Toshiyuki Miyashita, John C. Reed · Cell Open access 1995 4,079
18 Amino Acid Metabolism in Mammalian Cell Cultures Harry Eagle · Science 21 Aug 1959 4,032
19 Identification and expansion of human colon-cancer-initiating cells Lucia Ricci‐Vitiani, Dario Giuseppe Lombardi, Emanuela Pilozzi et al. · Nature 19 Nov 2006 4,008
20 Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium Toshiro Sato, Daniel E. Stange, Marc Ferrante et al. · Gastroenterology 3 Sep 2011 3,882
21 Microenvironmental regulation of metastasis Johanna A. Joyce, Jeffrey W. Pollard · Nature reviews. Cancer ReviewOpen access 12 Mar 2008 3,730
22 Clinical development and potential of photothermal and photodynamic therapies for cancer Xingshu Li, Jonathan F. Lovell, Juyoung Yoon et al. · Nature Reviews Clinical Oncology Review 22 Jul 2020 3,467
23 Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Walter Stummer, Uwe Pichlmeier, Thomas R. Meinel et al. · The Lancet Oncology 13 Apr 2006 3,416
24 p21 is a universal inhibitor of cyclin kinases Yue Xiong, Gregory James Hannon, Hui Zhang et al. · Nature Dec 1993 3,400
25 Pembrolizumab for Early Triple-Negative Breast Cancer Peter Schmid et al. · New England Journal of Medicine Open access 26 Feb 2020 3,298
26 Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Anne P. Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute 5 Jun 1991 3,295
27 Emerging Biological Principles of Metastasis Arthur W. Lambert, Diwakar Ram Pattabiraman, Robert A. Weinberg · Cell Open access Feb 2017 3,223
28 Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J L Cordell, Brunangelo Falini, Wendy N. Erber et al. · Journal of Histochemistry & Cytochemistry Feb 1984 3,212
29 Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene Michael E. Greenberg, Edward Benjamin Ziff · Nature Oct 1984 3,188
30 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Jamil Antonio Momand, Gerard P. Zambetti, David C. Olson et al. · Cell Jun 1992 3,151
31 p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al. · Cell Sep 1993 2,949
32 p53 is required for radiation-induced apoptosis in mouse thymocytes Scott W. Lowe, Earlene M. Schmitt, Sallie W. Smith et al. · Nature Apr 1993 2,903
33 Exploiting tumour hypoxia in cancer treatment J. Martin Brown, William Robert Wilson · Nature reviews. Cancer Review Jun 2004 2,847
34 A survey of telomerase activity in human cancer Jerry W. Shay, Silvia Bacchetti · European Journal of Cancer Apr 1997 2,806
35 Mutations in the p53 gene occur in diverse human tumour types Janice M. Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature Dec 1989 2,777
36 Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects Michael Höckel, Peter W. Vaupel · JNCI Journal of the National Cancer Institute Open access 21 Feb 2001 2,680
37 Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma Robert H.I. Andtbacka et al. · Journal of Clinical Oncology 27 May 2015 2,662
38 The human tumor microbiome is composed of tumor type–specific intracellular bacteria Deborah Nejman et al. · Science Open access 28 May 2020 2,523
39 Production of large amounts of hydrogen peroxide by human tumor cells. Ted P. Szatrowski, Carl Nathan · PubMed Feb 1991 2,519
40 A model for p53-induced apoptosis Kornélia Polyák, Yong Xia, Jay Louis Zweier et al. · Nature Sep 1997 2,514
41 Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Wen Xue, Lars Zender, Cornelius Miething et al. · Nature Open access 24 Jan 2007 2,483
42 Molecular principles of metastasis: a hallmark of cancer revisited Jawad Fares, Mohamad Y. Fares, Hussein H. Khachfe et al. · Signal Transduction and Targeted Therapy Open access 12 Mar 2020 2,454
43 Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer Robert Allen Burger, Mark F. Brady, Michael A. Bookman et al. · New England Journal of Medicine Open access 28 Dec 2011 2,422
44 Creation of human tumour cells with defined genetic elements William C. Hahn, Christopher M. Counter, Ante S. Lundberg et al. · Nature 29 Jul 1999 2,366
45 p53: puzzle and paradigm. L J Ko, Carol L. Prives · Genes & Development Open access May 1996 2,357
46 In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 Donald J. Giard, Stuart A. Aaronson, George J. Todaro et al. · JNCI Journal of the National Cancer Institute Nov 1973 2,340
47 Thymocyte apoptosis induced by p53-dependent and independent pathways Alan Richard Clarke, Colin A. Purdie, David James Harrison et al. · Nature Apr 1993 2,300
48 p53 in health and disease Karen H. Vousden, David Philip Lane · Nature Reviews Molecular Cell Biology Review 23 Mar 2007 2,281
49 Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain Paul H. Kussie, Svetlana S. Gorina, Vincent Maréchal et al. · Science 8 Nov 1996 2,246
50 Safety and antitumor activity of recombinant soluble Apo2 ligand Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation Open access 15 Jul 1999 2,234

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.